CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: cefalotin
Accession: CHEBI:124991
browse the term
Definition: A semisynthetic, first-generation cephalosporin antibiotic with acetoxymethyl and (2-thienylacetyl)nitrilo moieties at positions 3 and 7, respectively, of the core structure. Administered parenterally during surgery and to treat a wide spectrum of blood infections.
Synonyms: exact_synonym: (6R,7R)-3-(acetoxymethyl)-8-oxo-7-(thiophen-2-ylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-(thiophen-2-ylacetamido)-3-acetoxymethyl-3,4-didehydrocepham-4-carboxylic acid
related_synonym: 3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid; 7-(2-Thienylacetamido)cephalosporanic acid; 7-(Thiophene-2-acetamido)cephalosporin; CET; Cefalothin; Cephalothin; Cephalotin; Formula=C16H16N2O6S2; InChI=1S/C16H16N2O6S2/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23)/t12-,15-/m1/s1; InChIKey=XIURVHNZVLADCM-IUODEOHRSA-N; SMILES=[H][C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(O)=O)=C(COC(C)=O)CS[C@]12[H]; cefalotina; cefalotine; cefalotinum
alt_id: CHEBI:41547; CHEBI:50895
xref: Beilstein:945586; CAS:153-61-7; DrugBank:DB00456; Drug_Central:574; HMDB:HMDB0014599; KEGG:C07761; KEGG:D07635; LINCS:LSM-15184
xref_mesh: MESH:D002512
xref: PDBeChem:CLS; PMID:10930630; PMID:12569987; PMID:12833570; PMID:1384868; PMID:13963283; PMID:1701026; PMID:2083978; PMID:23472927; PMID:23680238; PMID:29017833; PMID:6176550; Patent:FR1384197; Patent:US3218318; Reaxys:945586; Wikipedia:Cephalothin
cyclic_relationship: is_conjugate_acid_of CHEBI:50897
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCB11 mRNA
CTD
PMID:24657338
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCC2 mRNA
CTD
PMID:24657338
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCC3 mRNA
CTD
PMID:24657338
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
Cephalothin results in increased expression of BAX protein
CTD
PMID:15012731
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Casp3
caspase 3
multiple interactions
ISO
Cephalothin results in increased cleavage of and results in increased activity of CASP3 protein
CTD
PMID:15012731
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in decreased expression of CYP8B1 mRNA
CTD
PMID:24657338
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Fgf19
fibroblast growth factor 19
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of FGF15 mRNA
CTD
PMID:24657338
NCBI chr 1:200,056,526...200,060,980
Ensembl chr 1:200,056,644...200,060,287
G
Npc1l1
NPC1 like intracellular cholesterol transporter 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of NPC1L1 mRNA
CTD
PMID:24657338
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of NR5A2 mRNA
CTD
PMID:24657338
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
G
Slc10a1
solute carrier family 10 member 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of SLC10A1 mRNA
CTD
PMID:24657338
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc25a20
solute carrier family 25 member 20
multiple interactions
EXP
Cephalothin binds to and results in decreased activity of SLC25A20 protein; Cephalothin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
G
Slc51b
SLC51 subunit beta
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA
CTD
PMID:24657338
NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
G
Slco1b2
solute carrier organic anion transporter family member 1B2
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of SLCO1B2 mRNA
CTD
PMID:24657338
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
G
Tp53
tumor protein p53
increases expression
ISO
Cephalothin results in increased expression of TP53 protein
CTD
PMID:15012731
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Vdr
vitamin D receptor
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of VDR mRNA
CTD
PMID:24657338
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all